Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Holmfridur Helgadottir"'
Publikováno v:
Pharmaceuticals, Vol 16, Iss 12, p 1722 (2023)
Proton pump inhibitor (PPI) treatment is responsible for substantial gastrin elevation secondary to reduced intragastric acidity. Due to the increasing global prevalence of PPI users, concerns have been raised about the clinical significance of conti
Externí odkaz:
https://doaj.org/article/9db36ffb399a4fabb4149cd8bb9815d5
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 21, p 5469 (2019)
Proton pump inhibitors (PPIs) are recommended as a first-line treatment for gastroesophageal reflux disease (GERD) and other acid related disorders. In recent years, concerns have been raised about the increasing prevalence of patients on long-term P
Externí odkaz:
https://doaj.org/article/b407dc91d3f74c4da4faba3e63502b56
Publikováno v:
Current Opinion in Gastroenterology. 39:83-88
Publikováno v:
Scandinavian journal of gastroenterology.
Patients with benign recurrent intrahepatic cholestasis (BRIC) suffer from recurrent episodes of cholestatic jaundice. Treatment options remain limited and are mainly symptomatic. In case reports rifampicin, plasmapheresis, and nasobiliary drainage h
Autor:
Manna Semere Gebreyesus, Eric Decloedt, Catherine A Cluver, Nicole Hunfeld, Holmfridur Helgadottir, Einar Björnsson, Roeland Wasmann, Paolo Denti
Esomeprazole is a proton pump inhibitor being investigated for treatment of preeclampsia. Esomeprazole pharmacokinetics during pregnancy is unknown. We used data from 10 pregnant patients with preterm preeclampsia, and 49 non-pregnant individuals to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60c4bb59bd0595417b808bb518175f9d
https://doi.org/10.22541/au.164600256.68927051/v1
https://doi.org/10.22541/au.164600256.68927051/v1
Autor:
Sigrun H. Lund, David C. Metz, Einar Bjornsson, Holmfridur Helgadottir, Sveinbjörn Gizurarson
Publikováno v:
J Clin Gastroenterol
Goals The goal of this study was to elucidate the most important predictors for elevation of gastrin in patients on long-term PPI therapy through analysis of data from 2 published studies in Icelandic patients with erosive GERD. Background Gastrin el
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 21, p 5469 (2019)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Proton pump inhibitors (PPIs) are recommended as a first-line treatment for gastroesophageal reflux disease (GERD) and other acid related disorders. In recent years, concerns have been raised about the increasing prevalence of patients on long-term P
Publikováno v:
Digestive and Liver Disease. 46:125-130
Dyspepsia develops in healthy volunteers after withdrawal of proton-pump inhibitors. This phenomenon, attributed to rebound acid hypersecretion, is thought to be mediated by reflex hypergastrinemia.To measure fasting and postprandial gastrin in patie
Autor:
Sigrun H. Lund, Holmfridur Helgadottir, Einar Bjornsson, Helge L. Waldum, Sveinbjörn Gizurarson
Publikováno v:
Gastroenterology. 156:S-308
Publikováno v:
Gastroenterology. 152:S468